INTRODUCTION
Many of the patients suffering from haematological malignancies benefit from the insertion of indwelling central venous lines as these provide reliable, pain free access for intravenous therapy (chemotherapy, intravenous fluids, blood transfusions etc ), venous sampling and total parenteral nutrition.' 2 Three different central venous catheters are inserted in our unit. Type A (Hickman®) lines are hollow silicone-rubber catheters which have central venous access through the internal jugular vein and exit, after a subcutaneous course, through the anterior chest area. Type B (Portacath®) catheters also gain central venous access through the internal jugular vein but, instead of coming out through the skin, end with a subcutaneous reservoir in the lower anterior chest area. This requires to be "plumbed in" using a specially designed needle prior to use. Type C (Pasport®) catheters also have a subcutaneous reservoir Patients with low platelet counts (< 50 x 1 09/L) were given platelet transfusions before and during the procedure. Following the procedure wound care was the responsibility of the nursing staff in the ward. Type B and C catheters did not require intensive wound management and clips were generally removed after 7 days. However with type A catheters management involved cleansing ofthe exit site on a daily basis with chlorhexidine and povidone iodine solutions. The catheter was flushed daily with 10 mls of heparinised saline when the line was not in use. All of the patients were given supervised training by nursing staff with regard to this procedure, and were subsequently able to perform this themselves at home. In conclusion these catheters improve quality of life although septic complications are a significant problem. Fortunately, the vast majority of these episodes can be satisfactorily controlled with antibiotics. Increasing experience in the use of these catheters, both by patients and by medical/nursing staff, and further improvement in the design and materials used in manufacture may lead to reduction in septic complications in the future. The role of prophylactic antibiotics requires further intensive investigation.
